Thrombolytic-Related Asymptomatic Hemorrhagic Transformation Does Not Deteriorate Clinical Outcome: Data from TIMS in China.

by Weihua Jia, Xiaoling Liao, Yuesong Pan, Yilong Wang, Tao Cui, Lichun Zhou, Yongjun Wang, TIMS-CHINA investigators
Published 2015-01-01

Relationship between Blood Pressure and Outcomes in Acute Ischemic Stroke Patients Administered Lytic Medication in the TIMS-China Study.

by Wei Wu, Xiaochuan Huo, Xingquan Zhao, Xiaoling Liao, Chunjuan Wang, Yuesong Pan, Yilong Wang, Yongjun Wang, TIMS-CHINA investigators
Published 2016-01-01

Benefit and risk of early intravenous heparin after thrombolysis in patients with acute ischemic stroke

by Xu Tong, Yibin Cao, Wenzhi Wang, David Wang, Yongjun Wang, Yilong Wang, the Thrombolysis Implementation, Monitor of Acute Ischemic Stroke in China (TIMS‐China) Investigators
Published 2020-10-01

Cost-effectiveness of thrombolysis within 4.5 hours of acute ischemic stroke in China.

by Yuesong Pan, Qidong Chen, Xingquan Zhao, Xiaoling Liao, Chunjuan Wang, Wanliang Du, Gaifen Liu, Liping Liu, Chunxue Wang, Yilong Wang, Yongjun Wang, TIMS-CHINA Investigators
Published 2014-01-01